Rocket Lab is running its strongest operational stretch ever, yet its shares have taken a punishing hit — fallout from a competitor’s massive market debut. The space upswing provides a snapshot of a company caught between stellar execution and sector-wide capital rotation.
The stock changed hands at €94.70 on Tuesday, down nearly 16% over the past month. That decline masks a year-to-date gain of roughly 46% and a longer-term trajectory that has more than quadrupled over the past twelve months. The trigger for the recent weakness was the initial public offering of rival SpaceX, which debuted with a valuation north of $2.1 trillion. Rather than lifting all boats, the mega-IPO sucked liquidity from the sector: Rocket Lab plunged almost 11% on the day of the debut.
Yet beneath the market noise, the operational machinery is humming. Rocket Lab’s launch complex in New Zealand is busier than ever, with more Electron rockets standing by for missions than at any point in the company’s history. The next flight, “Ten Owl Of Ten”, is scheduled for June 18 and will carry another StriX satellite for Japanese Earth-observation firm Synspective. That partnership, in place since 2020 and exclusive in nature, already has 17 more launches booked through 2030. The upcoming mission will be the 90th Electron flight overall.
Those launch cadences are translating directly into financial records. In the first quarter of 2026, Rocket Lab posted revenue of $200.3 million, a surge of 63.5% year over year. The order backlog ballooned to a fresh high of $2.2 billion, and management sold 31 new launch contracts in the quarter alone.
Should investors sell immediately? Or is it worth buying Rocket Lab?
But the quarter also brought a strategic leap. Rocket Lab signed a $90 million contract with the U.S. Space Force to develop, build, and operate two geostationary satellites. The move marks a significant expansion: until now the company has focused on low-Earth orbit. Entering the GEO class broadens its addressable market considerably and places it in direct contention for large government missions.
CEO Peter Beck has pointed to the sector-wide attention generated by competitor listings, arguing that Rocket Lab benefits as the clear number two U.S. rocket operator by launch count. The company is also pushing ahead with its next-generation Neutron rocket, designed to compete in the medium-lift segment. Rocket Lab has filed for launch licenses with the FAA, with the first flight window opening on July 1, 2026. Analysts at KeyBanc say a test setback in January has been fully resolved. Five firm launch contracts for Neutron were already signed in the first quarter.
The share price currently sits at €95.30, about 7% above its 50-day moving average. It remains roughly 29% below the all-time high of €133.80 reached in late May. Analysts remain largely constructive. Stifel recently lifted its price target to $132 with a buy rating. KGI Securities initiated coverage with a neutral stance and a $105 target. The average consensus estimate among analysts stands near $103.
A key near-term catalyst arrives on June 22, when Rocket Lab is set to join the Nasdaq-100 index. That inclusion will force many index-tracking funds to buy the stock, potentially providing a demand floor. If the operational momentum holds, the company could quickly absorb the shock of the SpaceX rotation — though the Neutron rocket’s debut remains the single biggest test of whether it can transform from a small-satellite specialist into a broad-based space player.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from June 16 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 16.
Rocket Lab: Buy or sell? Read more here...
